|
Volumn 22, Issue 9, 2003, Pages 903-906
|
Study on sero-diagnosis of nasopharyngeal carcinoma using a dual antibody test against recombinant Epstein-Barr virus antigens.
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BZLF1 PROTEIN, HERPESVIRUS 4, HUMAN;
DNA BINDING PROTEIN;
EBV ENCODED NUCLEAR ANTIGEN 1;
EBV-ENCODED NUCLEAR ANTIGEN 1;
EPSTEIN BARR VIRUS ANTIGEN;
IMMUNOGLOBULIN A;
RECOMBINANT PROTEIN;
TRANSACTIVATOR PROTEIN;
VIRUS ANTIBODY;
VIRUS PROTEIN;
ADULT;
ARTICLE;
BLOOD;
ENZYME LINKED IMMUNOSORBENT ASSAY;
HUMAN;
IMMUNOLOGY;
NASOPHARYNX TUMOR;
SENSITIVITY AND SPECIFICITY;
SEROLOGY;
VIROLOGY;
ADULT;
ANTIBODIES, VIRAL;
DNA-BINDING PROTEINS;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS;
HUMANS;
IMMUNOGLOBULIN A;
NASOPHARYNGEAL NEOPLASMS;
RECOMBINANT PROTEINS;
SENSITIVITY AND SPECIFICITY;
SEROLOGIC TESTS;
TRANS-ACTIVATORS;
VIRAL PROTEINS;
|
EID: 3843147470
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (0)
|